(redirected from Pari)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
References in periodicals archive ?
Based on PARI's over 100-years history working with aerosols, PARI Pharma develops treatments for pulmonary and nasal administration optimised with advanced delivery technologies, such as eFlow Technology.
because we believe Pari Gallery is not only selling products, but also selling comfort, convenience and a great shopping experience to clients.
PARI Respiratory exclusively markets Kitabis Pak and the compressor access program called PARI PROVIDE.
In addition to exclusively marketing Kitabis Pak, PARI also offers a compressor access program called PARI PROVIDE for patients who do not have the proper compressor to deliver the tobramycin inhalation solution.
About PARI PARI is a leading, worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, cystic fibrosis, RSV, VAP, and HAP.
Pari Networks is headquartered in Milpitas, CA and has a worldwide presence with offices in Americas, Asia and Europe.
We are excited about potential opportunities ahead of us working with Pari Networks.
The Protect, Conceal, and Enhance Eye Kit offers a dramatic result duo of Pari Beauty's No More Circles Eye Gel, an herbal based protective and repairing gel that alleviates dark eye circles and puffiness while also reducing fine lines and wrinkles.
Kamada has also signed a strategic agreement with PARI, a Germany-based world leader in aerosol therapies, for the conjoint clinical development and marketing of API administered by inhalation.
Vios includes either two PARI LC PLUS or two PARI LC Sprint nebulizers, allowing physicians to make the choice best suited to the situation.
reported positive top line results from a Phase 2b clinical trial with Aeroquin, a novel aerosol formulation of levofloxacin delivered by an optimized Investigational eFlow Nebulizer System from PARI Pharma.
July 21 /PRNewswire/ -- Today, PARI Respiratory Equipment was granted a US Patent for its Vortex Holding Chamber, a unique, non-electrostatic, holding chamber with a one piece, dual-valve system that optimizes patient inhalation and exhalation for more efficient medication delivery with a metered dose inhaler (MDI).